
09/02/2025
👏 Good news for patients! ➡️ The FDA has approved biosimilars Bildyos and Bilprevda (denosumab-nxxp). This important milestone expands treatment options for those living with osteoporosis and cancer-related bone conditions. Congratulations Organon and Henlius! Learn more here: https://www.organon.com/news/us-food-and-drug-administration-fda-approves-henlius-and-organons-bildyos-denosumab-nxxp-and-bilprevda-denosumab-nxxp-biosimilars-to-prolia-denosumab-and-xgeva-denosumab